Want to see GB:TCF full AI Analyst Report?
Total Valuation
Evgen Pharma has a market cap or net worth of £4.92M. The enterprise value is 2.66 p.
Market Cap£4.92M
Enterprise Value2.66 p
Share Statistics
Evgen Pharma has 2,732,297,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,732,297,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Evgen Pharma’s return on equity (ROE) is -1.30 and return on invested capital (ROIC) is -116.18%.
Return on Equity (ROE)-1.30
Return on Assets (ROA)-0.73
Return on Invested Capital (ROIC)-116.18%
Return on Capital Employed (ROCE)-1.18
Revenue Per Employee0.00
Profits Per Employee-392.33K
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Evgen Pharma is ―. Evgen Pharma’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio1.54
Price to Fair Value1.54
Price to FCF-1.63
Price to Operating Cash Flow-1.57
PEG Ratio0.02
Income Statement
In the last 12 months, Evgen Pharma had revenue of 0.00 and earned -3.53M in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit-16.00K
Operating Income-3.69M
Pretax Income-3.57M
Net Income-3.53M
EBITDA-3.67M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.55M and capital expenditures -17.00K, giving a free cash flow of -2.56M billion.
Operating Cash Flow-2.55M
Free Cash Flow-2.56M
Free Cash Flow per Share>-0.01
Dividends & Yields
Evgen Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change-18.18%
50-Day Moving Average0.19
200-Day Moving Average0.21
Relative Strength Index (RSI)44.78
Average Volume (3m)1.74M
Important Dates
Evgen Pharma upcoming earnings date is Dec 9, 2026, TBA (Confirmed).
Last Earnings DateJun 10, 2026
Next Earnings DateDec 9, 2026
Ex-Dividend Date―
Financial Position
Evgen Pharma as a current ratio of 1.36, with Debt / Equity ratio of 0.40%
Current Ratio1.36
Quick Ratio1.36
Debt to Market Cap<0.01
Net Debt to EBITDA0.13
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Evgen Pharma has paid -37.00K in taxes.
Income Tax-37.00K
Effective Tax Rate0.01
Enterprise Valuation
Evgen Pharma EV to EBITDA ratio is -1.02, with an EV/FCF ratio of -1.45.
EV to Sales0.00
EV to EBITDA-1.02
EV to Free Cash Flow-1.45
EV to Operating Cash Flow-1.46
Balance Sheet
Evgen Pharma has £1.54M in cash and marketable securities with £11.00K in debt, giving a net cash position of £1.53M billion.
Cash & Marketable Securities£1.54M
Total Debt£11.00K
Net Cash£1.53M
Net Cash Per Share<£0.01
Tangible Book Value Per Share<£0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Evgen Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast55.56%